ANI Pharmaceuticals, Inc. FDA Inspection Record

FEI 2111358 · Inspections, Form 483s, warning letters and import refusals

ANI Pharmaceuticals, Inc. is an FDA-registered facility (FEI 2111358) located in Baudette, MN, US. Registered operations: LABEL; PACK. RegDataLab tracks 10 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Dec 6, 2024: Voluntary Action Indicated (VAI)
Inspections on record
10 (5 VAI, 5 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
3, latest Jun 2, 2026

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Dec 6, 2024Voluntary Action Indicated (VAI)No citations listed
Nov 18, 2022Voluntary Action Indicated (VAI)No citations listed
Apr 12, 2019No Action Indicated (NAI)No citations listed
Jul 28, 2016No Action Indicated (NAI)Late submission of 15-day report (21 CFR 314.80(c)(1)(i))
Sep 27, 2013No Action Indicated (NAI)No citations listed
Jan 6, 2012Voluntary Action Indicated (VAI)No citations listed
Sep 16, 2011Voluntary Action Indicated (VAI)No citations listed
Sep 15, 2011No Action Indicated (NAI)No citations listed
Jan 29, 2010Voluntary Action Indicated (VAI)Scientifically sound laboratory controls (21 CFR 211.160(b))
Jan 28, 2010No Action Indicated (NAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Jun 2, 2026Class IIID-0619-2026hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint), Rx only…
Presence of foreign substance
May 12, 2026Class IID-0543-2026Estradiol Gel, 0.1%, 0.25 mg, 0.25 g per packet, 30 packets per carton, Rx only…
Defective Container; packets were found to be either empty or partially full.
Feb 15, 2022Class IID-0564-2022Alprazolam Tablets, USP 0.25 mg, packaged in a) 100-count bottles (NDC 67253-900-10), b)… and 4 more products
cGMP Deviations

FDA record score

16 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 16, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

7 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIDec 6, 20246 x 16
Class II recall D-0543-2026, this FEI as the recalling firmMay 12, 20264 x 14
Inspection classified VAINov 18, 20226 x 0.63.6
Class II recall D-0564-2022, this FEI as the recalling firmFeb 15, 20224 x 0.62.4
Inspection classified VAIJan 6, 201210 years or older, so it adds no points0
Inspection classified VAISep 16, 201110 years or older, so it adds no points0
Inspection classified VAIJan 29, 201010 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing ANI Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check ANI Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
ANI Pharmaceuticals, Inc.
Location
Baudette, MN (US)
Registration Expires
Dec 31, 2027
Operations
LABEL; PACK
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.